Advances in Pancreatic Cancer Research: Q&A With Christine Iacobuzio-Donahue, MD, PhD
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
AACR President Nancy E. Davidson, MD, discusses her goals for her Presidential year at the AACR in an editorial...
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal...
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
The potential for developing new immunotherapies and expanding the use of existing ones will be the focus of the...
Levi Garraway, MD, PhD, co-chair of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston Nov....
Guest Post by Daniel Lee Miller, MD, PhD (@Dan_Lee_Miller) Associate member of the AACR and resident physician in Pathology,...
The AACR is a founder and organizing partner of the Rally for Medical Research, which took place for the...
Learn how liquid biopsy could be used to detect cancer and guide treatment as researchers work to develop more...
The U.S. Food and Drug Administration (FDA) recently added a new therapeutic to the armamentarium for oncologists treating patients...
A study published recently in the AACR’s journal Cancer Discovery addresses the burgeoning question of the utility of high-throughput...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
The flurry of anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) late last month included the...
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...
Back for the new year, here are the editors’ selections for the January issues of the eight scientific journals...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
The National Women’s Survivors Convention wrapped up on Saturday, Aug. 2, in Nashville, Tennessee. The convention, just in its second...
By Cancer Today Staff News stories about efforts to eliminate and prevent cancer often tell the story in broad...
February is drawing to a close, and it’s time for our monthly staple: the collection of 10 “must read”...
Last week, the U.S. Food and Drug Administration (FDA) approved the use of cobimetinib (Cotellic) in combination with vemurafenib...
In 2018, we witnessed significant momentum in several hot areas of cancer research, including immunotherapy and precision medicine. Researchers...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...
Back for the month of June are the editors’ picks from the eight scientific journals published by the American...
Later this week, more than 200 researchers will convene in Montreal for a four-day conference on DNA Repair: Tumor...
The first allogeneic hematopoietic-cell transplant (HCT)—a complex procedure where a patient receives blood stem cells isolated from a healthy...
For Bruce Hill, who was diagnosed with stage 4 clear cell renal cell carcinoma (RCC) in 2017, scientific progress...
As we celebrate National Cancer Survivor Month, we are aware how the term survivor can take on many meanings...